Samsung BioLogics submits application for IPO plan – The Korea Herald

Samsung BioLogics submits application for IPO plan
The Korea Herald
Samsung BioLogics Co., a medicine-producing subsidiary of South Korea's Samsung Group, on Friday applied for preliminary approval for its planned initial public offering, the local bourse announced. The Korea Exchange is required to inform Samsung …
BRIEF-Zhejiang Haers Vacuum Containers plans two unit in HangzhouReuters
South Korea to Review Toxins Data Disclosure ProcessNew York Times
Samsung BioLogics applies for Seoul exchange IPO approvalReuters UK
Wall Street Journal –AppleInsider (press release) (blog) –Philly.com –Digital Trends
all 138 news articles »